Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis

Marta Corsetti1, Gabriella Ruocco2, Serena Ruggieri3

  • 1Neuroimmunology Unit, IRCSS Fondazione Santa Lucia, 00143 Rome, Italy. m.corsetti@hsantalucia.it.

Abstract

Insights

Plasmacytoid dendritic cells (pDCs) show enhanced activation in multiple sclerosis (MS) patients, potentially due to viral infections. These pDCs express higher costimulatory molecules, suggesting a protective role against viral triggers in MS.

Area of Science:

  • Immunology
  • Neuroscience
  • Virology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system.
  • Genetic and environmental factors, including viral infections, are implicated in MS pathogenesis.
  • Dendritic cells (DCs), including myeloid DCs (mDCs) and plasmacytoid DCs (pDCs), play a crucial role in antiviral responses and adaptive immunity.

Purpose of the Study:

  • To investigate the response of pDCs and mDCs to viral mimicry in multiple sclerosis patients.
  • To compare the expression of costimulatory molecules on DCs from healthy donors and MS patients upon stimulation with a viral mimic.

Main Methods:

  • Mimicked viral infection using synthetic single-strand RNA (Resiquimod).
  • Compared the response of pDCs and mDCs from healthy donors and MS patients.
  • Characterized the surface expression of costimulatory molecules on DCs.

Main Results:

  • pDCs from MS patients exhibited higher expression of OX40-L, HLA-DR, and CD86 compared to healthy donors.
  • Resiquimod stimulation enriched a subpopulation of pDCs with high costimulatory molecule expression in both MS patients and healthy donors.
  • These findings suggest an enhanced activation state of pDCs in MS.

Conclusions:

  • pDC activation appears to be heightened in multiple sclerosis, potentially linked to latent viral infections.
  • The increased expression of costimulatory molecules on pDCs may represent a protective mechanism against viral triggers contributing to MS autoimmunity.

Related Concept Videos

BJT Amplifiers01:14

BJT Amplifiers

Bipolar Junction Transistors (BJTs) are pivotal components in amplifier circuits, functioning as voltage-controlled current sources in their active region. This characteristic allows them to efficiently control the collector current through variations in the base-emitter voltage. Essentially, BJTs amplify power due to their ability to take a weak input signal and output a much stronger signal.
In BJT amplifier configurations, particularly in common-emitter setups, the transistor's role...
970
Operational Amplifiers01:17

Operational Amplifiers

The operational amplifier, often referred to as an op-amp, is a multifaceted building block of a circuit. This electronic component functions like a voltage-controlled voltage source and can also be used to create a voltage- or current-controlled current source. The design of an operational amplifier enables it to execute mathematical operations when external components like resistors and capacitors are linked to its terminals. An op-amp has the capacity to sum signals, amplify a signal,...
1.9K
MOSFET Amplifiers01:17

MOSFET Amplifiers

The MOSFET, when operating in its active region, functions as a voltage-controlled current source. In this region, the gate-to-source voltage controls the drain current. This principle underlies the operation of the transconductance MOSFET amplifier. The output current is directed through a load resistor to convert this amplifier into a voltage amplifier. The output voltage is then obtained by subtracting the voltage drop across the load resistance from the supply voltage. This process results...
506
Instrumentation Amplifier01:25

Instrumentation Amplifier

An electrocardiography (ECG) machine is an essential piece of medical equipment used to monitor the electrical activity of the heart. It operates by detecting small electrical changes on the skin that result from the depolarization of the heart muscle during each heartbeat. However, these signals are in the microvolt range and can be easily overwhelmed by noise or interference.
To overcome this challenge, an ECG machine utilizes an instrumentation amplifier. This specialized amplifier is...
1.0K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
8.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.6K